Investment Adventures in Emerging Markets

Chinese equities poised to rebound after unsustainable low
Asia

Chinese equities poised to rebound after unsustainable low

Positive catalysts, such as the anticipated easing of both COVID-19 restrictions and geopolitical tensions, paired with policy loosening, may help the Chinese equity market recover, according to Franklin Templeton Emerging Market Equity’s Michael Lai. He shares his latest outlook and where he finds investment opportunities.

Chinese Equities: Conviction Amid Change in the Year of the Tiger
Asia

Chinese Equities: Conviction Amid Change in the Year of the Tiger

The upcoming Chinese New Year will usher in the Year of the Tiger, an animal in the Chinese zodiac widely associated with strength and courage. Franklin Templeton Emerging Markets Equity’s Michael Lai discusses his constructive outlook for China and the investment opportunities he sees.

Socialism with Chinese Characteristics: Understanding China’s Policymaking
Asia

Socialism with Chinese Characteristics: Understanding China’s Policymaking

The latest issue of “Trends Reinforced” examines the strategic goals that have shaped China’s latest regulatory moves. Read an excerpt from Portfolio Manager Michael Lai.

Bridging the ESG Gap in China
Perspective

Bridging the ESG Gap in China

Is China’s ambition to become carbon neutral by 2060 viable? A look at what these ambitions say about the country’s wider ESG goals.

Chinese New Year: How Investors Might Navigate Markets in the Year of the Ox
Asia

Chinese New Year: How Investors Might Navigate Markets in the Year of the Ox

Ahead of the new lunar year, our Stephen Tong, Desmond Soon and Michael Lai weigh in on how investors might navigate Asian markets with the characteristics of the Chinese zodiac’s ox in mind, traditionally associated with patience, diligence and persistence.

China 2021 Outlook: Pandemic Fuels Momentum for De-Globalization, What’s Next?
Asia

China 2021 Outlook: Pandemic Fuels Momentum for De-Globalization, What’s Next?

How might China’s health care story unfold in 2021 and beyond? Read Chetan Sehgal and Michael Lai’s outlook here.

Health Care: The Next Wave of Innovation in China
Asia

Health Care: The Next Wave of Innovation in China

Our Emerging Markets Equity team's Michael Lai and Elizabeth Wu take a look at a new breed of innovative enterprises in China that could transform health care outcomes in the years ahead.

ESG Gains Traction in China as Investor Base Expands
Asia

ESG Gains Traction in China as Investor Base Expands

Franklin Templeton Emerging Markets Equity’s Michael Lai weighs in on some emerging trends he’s seen on ESG issues in China.

US-China Trade Tensions Resurface as Lockdowns Lift
Asia

US-China Trade Tensions Resurface as Lockdowns Lift

As China’s economy continues to recover from the COVID-19 lockdown, other issues—such as trade tensions—have started to resurface. Portfolio Manager Michael Lai offers his perspective from an investment lens on trade and other issues impacting China today.

China Uses the Appropriate Tools in Its Kit—What’s Next for Chinese Equities?
Asia

China Uses the Appropriate Tools in Its Kit—What’s Next for Chinese Equities?

What could a recovery look like for Chinese equities? Thoughts from Franklin Templeton Emerging Markets Equity’s Michael Lai.

China Lifts Foreign Investor Caps on Stock and Bond Markets
Asia

China Lifts Foreign Investor Caps on Stock and Bond Markets

China has long limited foreign investor access to its capital markets. However, the country recently announced it will lift restrictions, a move that further opens its markets to the global investment community. Franklin Templeton Emerging Markets Equity Portfolio Manager Michael Lai, who is based in Hong Kong, explains what this means.